Accessibility Skip to Global Navigation Skip to Local Navigation Skip to Content Skip to Search Skip to Site Map Menu

Dr Helen Lunt

MB ChB(Brist) DM(S'ton) FRACP

Email helen.lunt@cdhb.health.nz

Diabetes Centre
Christchurch Hospital
Private Bag 4710
Christchurch
New Zealand

Current Roles

  • Diabetes Physician, Christchurch Diabetes Centre
  • Clinical Director, Health Innovation Hub, Canterbury District Health Board
  • Clinical Associate Professor, University of Otago, Christchurch

Research Interests

  • Diabetes Service delivery
  • Diabetes Clinical Trials 
  • Clinical applications of diabetes technologies 

^ Top of page

Publications

Lunt, H., Heenan, H., & Chan, H. (2018). Exploring phenotype-genotype correlations using interstitial glucose results in a family with a glucokinase mutation. Journal of Diabetes Science & Technology. Advance online publication. doi: 10.1177/1932296818784064

Thompson, H., Lunt, H., Fleckney, C., & Soule, S. (2018). Insulin degludec overdose in an adolescent with type 1 diabetes: Proactive management including monitoring using the Freestyle Libre flash glucose monitoring system. Endocrinology, Diabetes & Metabolism Case Reports, 18-0044. doi: 10.1530/edm-18-0044

Lunt, H., Heenan, H. F., Edwards, P., & Florkowski, C. M. (2018). Impact of citrated blood collection tubes on red cell morphology: Implications for the measurement of plasma glucose. Clinical Chemistry & Laboratory Medicine, 56(4), 97. doi: 10.1515/cclm-2017-0790

Lunt, H., Prickett, T., Warwick, J., Heenan, H., & Espiner, E. (2018). C-type natriuretic peptide as a candidate marker of diabetic kidney disease. Diabetologia, 61(Suppl. 1), (pp. S493). doi: 10.1007/s00125-018-4693-0

Lunt, H., & Burtun, R. (2018, August). Insulin masterclass: Advanced. Workshop presentation at the 9th South General Practice Conference & Medical Exhibition (GP CME), Christchurch, New Zealand.

Journal - Research Article

Macdonald, C., Lunt, H., Downie, M., & Kendall, D. (2017). How satisfied are patients when their choice of funded glucose meter is restricted to a single brand? Journal of Diabetes Science & Technology, 11(5), 1001-1006. doi: 10.1177/1932296817693016

Mansell, E., Lunt, H., & Docherty, P. (2017). Laboratory diagnosis of gestational diabetes: An in silico investigation into the effects of pre-analytical processing on the diagnostic sensitivity and specificity of the oral glucose tolerance test. Clinical Biochemistry, 50(9), 506-512. doi: 10.1016/j.clinbiochem.2017.01.012

Lee, I., Lunt, H., Chan, H., Heenan, H., Berkeley, J., & Frampton, C. M. A. (2016). Postprandial capillary-venous glucose gradient in Type 1 diabetes: Magnitude and clinical associations in a real world setting. Diabetic Medicine, 33(7), 998-1003. doi: 10.1111/dme.13025

Carey, R., Lunt, H., Heenan, H. F., Frampton, C. M. A., & Florkowski, C. M. (2016). Collection tubes containing citrate stabiliser over-estimate plasma glucose, when compared to other samples undergoing immediate plasma separation. Clinical Biochemistry, 49(18), 1406-1411. doi: 10.1016/j.clinbiochem.2016.05.017

Bergenstal, R. M., Lunt, H., Franek, E., Travert, F., Mou, J., Qu, Y., … on behalf of the IMAGINE 3 Trial Investigators. (2016). Randomized, double-blind clinical trial comparing basal insulin peglispro and insulin glargine, in combination with prandial insulin lispro, in patients with type 1 diabetes: IMAGINE 3. Diabetes, Obesity & Metabolism, 18(11), 1081-1088. doi: 10.1111/dom.12698

Su, H., Lunt, H., & Hoeben, K. (2016). Resilience in youth with type 1 diabetes following an earthquake. Australasian Journal of Disaster & Trauma Studies, 20(2, Spec. Iss.), 101-105. Retrieved from http://trauma.massey.ac.nz/index.html

McEntyre, C. J., Lever, M., Chambers, S. T., George, P. M., Slow, S., Elmslie, J. L., Florkowski, C. M., Lunt, H., & Krebs, J. D. (2015). Variation of betaine, N,N-dimethylglycine, choline, glycerophosphorylcholine, taurine, and trimethylamine-N-oxide in the plasma and urine of overweight people with type 2 diabetes over a two-year period. Annals of Clinical Biochemistry, 52(3), 352-360. doi: 10.1177/0004563214545346

Lunt, H., Draper, N., Marshall, H. C., Logan, F. J., Hamlin, M. J., Shearman, J. P., Cotter, J. D., … Frampton, C. M. A. (2014). High intensity interval training in a real world setting: A randomized controlled feasibility study in overweight inactive adults, measuring change in maximal oxygen uptake. PLoS ONE, 9(1), e83256. doi: 10.1371/journal.pone.0083256

Lever, M., McEntyre, C. J., George, P. M., Slow, S., Elmslie, J. L., Lunt, H., Chambers, S. T., Parry-Strong, A., & Krebs, J. D. (2014). Extreme urinary betaine losses in type 2 diabetes combined with bezafibrate treatment are associated with losses of dimethylglycine and choline but not with increased losses of other osmolytes. Cardiovascular Drugs & Therapy, 28, 459-468. doi: 10.1007/s10557-014-6542-9

Parwaiz, M., Lunt, H., Florkowski, C. M., Logan, F. J., Irons, L., Perwick, C., Frampton, C. M. A., & Moore, M. P. (2014). Assessment of glucose meter performance at the antenatal diabetes clinic: Exploration of patient-related and pre-analytical factors. Annals of Clinical Biochemistry, 51(1), 47-53. doi: 10.1177/0004563213487893

Chan, H., Lunt, H., Thompson, H., Heenan, H. F., Frampton, C. M. A., & Florkowski, C. M. (2014). Plasma glucose measurement in diabetes: Impact and implications of variations in sample collection procedures with a focus on the first hour after sample collection. Clinical Chemistry & Laboratory Medicine, 52(7), 1061-1068. doi: 10.1515/cclm-2013-1059

Yong, K. W., Moore, M. P., & Lunt, H. (2014). Medically facilitated discharge of adult diabetic ketoacidosis admissions: Precipitants and average length of stay. New Zealand Medical Journal, 127(1392). Retrieved from http://www.nzma.org.nz/journal

Swaminathan, A., Lunt, H., Frampton, C. M. A., & Florkowski, C. M. (2013). What is the lower limit for postprandial venous plasma glucose in healthy young adults? Annals of Clinical Biochemistry, 50(6), 614-617. doi: 10.1177/0004563213481451

Swaminathan, A., Lunt, H., Chang, W. S. J., Logan, F. J., Frampton, C. M. A., & Florkowski, C. M. (2013). Impact of prandial status on the comparison of capillary glucose meter and venous plasma glucose measurements in healthy volunteers. Annals of Clinical Biochemistry, 50(1), 6-12. doi: 10.1258/acb.2012.012084

Braatvedt, G. D., Cundy, T., Crooke, M., Florkowski, C., Mann, J. I., Lunt, H., … Drury, P. L. (2012). Understanding the new HbA1c units for the diagnosis of Type 2 diabetes [Review article]. New Zealand Medical Journal, 125(1362). Retrieved from http://www.nzma.org.nz/journal

Ellis, E., Chin, P. K. L., Hunt, P. J., Lunt, H., Lewis, J. G., & Soule, S. G. (2012). Is late-night salivary cortisol a better screening test for possible cortisol excess than standard screening tests in obese patients with Type 2 diabetes? New Zealand Medical Journal, 125(1353). Retrieved from http://www.nzma.org.nz/journal

Krebs, J. D., Elley, C. R., Parry-Strong, A., Lunt, H., Drury, P. L., Bell, D. A., … Mann, J. I. (2012). The Diabetes Excess Weight Loss (DEWL) trial: A randomised controlled trial of high-protein versus high-carbohydrate diets over 2 years in type 2 diabetes. Diabetologia, 55, 905-914. doi: 10.1007/s00125-012-2461-0

McLachlan, C. Y. L., Beach, R., Laing, R., Frazer, G., Lunt, H., & Cawood, T. J. (2011). Could glucose self-monitoring become the preferred tool for screening and monitoring glucose control in cystic fibrosis? Practical Diabetes International, 28(4), 173-176. doi: 10.1002/pdi.1587

Storer, M., Dummer, J., Lunt, H., Scotter, J., McCartin, F., Cook, J., Swanney, M., … Epton, M. (2011). Measurement of breath acetone concentrations by selected ion flow tube mass spectrometry in type 2 diabetes. Journal of Breath Research, 5, 046011. doi: 10.1088/1752-7155/5/4/046011

Ellis, E., Ballance, K., Lunt, H., & Lewis, D. (2010). Diabetes outpatient care before and after admission for diabetic foot complications. Journal of Wound Care, 19(4), 150-152.

Whitehead, C., Lunt, H., Pearson, J. F., & Cawood, T. J. (2010). Is screening for hypothyroidism in the diabetes clinic effective? Practical Diabetes International, 27(3), 113-117. doi: 10.1002/pdi.1458

Lunt, H., Florkowski, C., Bignall, M., & Budgen, C. (2010). Capillary glucose meter accuracy and sources of error in the ambulatory setting. New Zealand Medical Journal, 123(1310). Retrieved from http://journal.nzma.org.nz/journal/123-1308/3945/content.pdf

Doogue, M. P., Begg, E. J., Moore, M. P., Lunt, H., Pemberton, C. J., & Zhang, M. (2009). Metformin increases plasma ghrelin in Type 2 diabetes. British Journal of Clinical Pharmacology, 68(6), 875-882. doi: 10.1111/j.1365-2125.2009.03372.x

Greenslade, M. E., Lunt, H., Kendall, D., & Frampton, C. M. (2009). 'Introduction to Insulin' classes: Flexible approach to insulin initiation. Practical Diabetes International, 26(4), 142-144. doi: 10.1002/pdi.1357

Florkowski, C., Budgen, C., Kendall, D., Lunt, H., & Moore, M. P. (2009). Comparison of blood glucose meters in a New Zealand diabetes centre. Annals of Clinical Biochemistry, 46, 302-305. doi: 10.1258/acb.2009.008193

Moses, R. G., Bartley, P., Lunt, H., O'Brien, R. C., Donnelly, T., Gall, M.-A., … Roberts, A. (2009). Safety and efficacy of inhaled insulin (AERx® iDMS) compared with subcutaneous insulin therapy in patients with Type 1 diabetes: 1-year data from randomized, parallel group trial. Diabetic Medicine, 26(3), 260-267. doi: 10.1111/j.1464-5491.2008.02654.x

Scott, A., Toomath, R., Bouchier, D., Bruce, R., Crook, N., Carroll, D., … Lunt, H., Wiltshire, E., & Wu, D. (2006). First national audit of the outcomes of care in young people with diabetes in New Zealand: High prevalence of nephropathy in Māori and Pacific Islanders. New Zealand Medical Journal, 119(1235). Retrieved from http://journal.nzma.org.nz/journal/119-1235/2015/content.pdf

Wu, D., Kendall, D., Lunt, H., Willis, J., Darlow, B., & Frampton, C. (2005). Prevalence of type 1 diabetes in New Zealanders aged 0-24 years. New Zealand Medical Journal, 118(1218). Retrieved from http://journal.nzma.org.nz/journal/118-1218/1557/content.pdf

Lunt, H., Kendall, D., Moore, M. P., Scott, R. S., Cole, D., Frampton, C. M., & Cullens, M. (2004). Prospective audit of conversion from regular to lispro insulin during routine clinical care. Internal Medicine Journal, 34(3), 320-323.

Wilson, M., Moore, M. P., & Lunt, H. (2004). Treatment satisfaction after commencement of insulin in Type 2 diabetes. Diabetes Research & Clinical Practice, 66, 263-267. Elsevier.

Lim, D., Lunt, H., Ojala, R., & Turner, J. (2004). Simultaneous presentation of Type 1 diabetes and thyrotoxicosis as a medical emergency [Case notes]. New Zealand Medical Journal, 117(1189). Retrieved from http://journal.nzma.org.nz/journal/117-1189/775/content.pdf

Willis, J., Scott, R. S., Darlow, B. A., Nesbit, J., Anderson, P., Moore, M. P., Lunt, H., & Cole, D. R. (2002). Incidence of type 1 diabetes mellitus diagnosed before age 20 years in Canterbury, New Zealand over the last 30 years. Journal of Pediatric Endocrinology & Metabolism, 15, 637-643.

Surgenor, L. J., Horn, J., Hudson, S. M., Lunt, H., & Tennent, J. (2000). Metabolic control and psychological sense of control in women with diabetes mellitus: Alternative considerations of the relationship. Journal of Psychosomatic Research, 49, 267-273.

Moore, M. P., & Lunt, H. (2000). Diabetes in New Zealand. Diabetes Research & Clinical Practice, 50(Suppl. 2), S65-S71.

Lunt, H., & Moore, M. P. (2000). Type 2 diabetes and tight blood pressure control: How low to go? New Zealand Medical Journal, 113, 90-91.

Kendall, D., Lunt, H., Moore, M. P., & McSweeney, W. P. (1999). Diabetes complication screening in general practice: a two pass audit with benchmarking. New Zealand Medical Journal, 112, 141-145.

Dellow, W. J., Chambers, S., Lever, M., Lunt, H., & Robson, R. A. (1999). Elevated glycine betaine excretion in diabetes mellitus patients is associated with proximal tubular dysfunction and hyperglycemia. Diabetes Research & Clinical Practice, 43(2), 91-99.

Lunt, H., Beard, M. E. J., Kendall, D., Wilson, M. A., & Frampton, C. M. (1999). Cerebrovascular disease as a general medicine discharge diagnosis: assessment of diagnostic agreement on case note review. Australian & New Zealand Journal of Medicine, 29, 319-323.

Lunt, H., Florkowski, C. M., Cundy, T., Kendall, D., Brown, L. J., Elliot, J. R., Wells, J. E., & Turner, J. G. (1998). A population-based study of bone mineral density in women with longstanding Type 1 (insulin dependent) diabetes. Diabetes Research & Clinical Practice, 40(1), 31-38. doi: 10.1016/S0168-8227(98)00012-6

Willis, J., Scott, R. S., Darlow, B. A., Lunt, H., & Moore, P. (1997). Hepatitis B immunisation and the epidemiology of IDDM in children and adolescents aged <20 years in Canterbury, New Zealand. Diabetes, 46(Suppl. 1), 140A.

Lunt, H. (1996). Women and diabetes. Diabetic Medicine, 13(12), 1009-1016.

Lunt, H., & Brown, L. J. (1996). Self-reported changes in capillary glucose and insulin requirements during the menstrual cycle. Diabetic Medicine, 13, 525-530.

^ Top of page

Journal - Research Other

Lunt, H., Heenan, H., & Chan, H. (2018). Exploring phenotype-genotype correlations using interstitial glucose results in a family with a glucokinase mutation. Journal of Diabetes Science & Technology. Advance online publication. doi: 10.1177/1932296818784064

Lunt, H., Heenan, H. F., Edwards, P., & Florkowski, C. M. (2018). Impact of citrated blood collection tubes on red cell morphology: Implications for the measurement of plasma glucose. Clinical Chemistry & Laboratory Medicine, 56(4), 97. doi: 10.1515/cclm-2017-0790

Thompson, H., Lunt, H., Fleckney, C., & Soule, S. (2018). Insulin degludec overdose in an adolescent with type 1 diabetes: Proactive management including monitoring using the Freestyle Libre flash glucose monitoring system. Endocrinology, Diabetes & Metabolism Case Reports, 18-0044. doi: 10.1530/edm-18-0044

Heenan, H., Lunt, H., Chan, H., & Frampton, C. M. (2017). How much hemolysis is acceptable when undertaking deep lancing for finger stick derived capillary plasma glucose measurement? Journal of Diabetes Science & Technology, 11(4), 845-846. doi: 10.1177/1932296816688013

Lunt, H., & Hudson, B. (2017). Metformin: A golden oldie. New Zealand Medical Journal, 130(1465), 9-11. Retrieved from http://www.nzma.org.nz/journal

Heenan, H., Lunt, H., Chan, H., & Frampton, C. M. (2017). Capillary samples and hemolysis: Further considerations. Journal of Diabetes Science & Technology, 11(4), 847-848. doi: 10.1177/1932296817700921

Carey, R. J., Churcher, M., Hughes, R., Florkowski, C. M., Frampton, C. M., Heenan, H. F., & Lunt, H. (2017). Will the use of lyophilized citrate tubes lead to the over-diagnosis of diabetes in pregnancy? Journal of Applied Laboratory Medicine, 1(5), 592-594. doi: 10.1373/jalm.2016.022103

Lunt, H. (2017). Incorrect AM/PM insulin pump clock settings can result in an unstable insulin dosing feedback loop. Journal of Diabetes Science & Technology, 11(4), 842-843. doi: 10.1177/1932296816678633

More publications...